Tern Plc Sells Part Holding in Device Authority

Tern plc

Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things (“IoT”) technology businesses, has announced that it has sold part of its shareholding in Device Authority Limited for a total cash consideration of £233,000. As a consequence, Tern’s holding in Device Authority has reduced from 31.7% to 30.0% (before any dilution on the exercise of share options and the expected closing of Tranche Two of the Device Authority Fundraising announced on 27 December 2023).

This sale of equity in Device Authority equated to approximately 5.3% of Tern’s holding in Device Authority and has been undertaken at the same price as the Device Authority Fundraising announced by the Company on 27 December 2023 (the “Device Authority Fundraising Issue Price”). The buyer of Tern’s equity in Device Authority is an independent family office who are not currently a shareholder in Device Authority and not related to Tern. The proceeds of this disposal will be used to invest further in one or more of Tern’s portfolio companies and for general corporate purposes.

Tern’s reduced holding of 30.0% in Device Authority (before any dilution on exercise of share options and the expected closing of Tranche Two) has an unaudited book valuation of approximately US$5.4 million (approximately £4.2 million) at the valuation implied by the Device Authority Fundraising Issue Price.

The remaining Tranche Two of the Device Authority Fundraising of US$3.3 million, by Ten Eleven Ventures remains, as previously announced, to be completed on or prior to 30 September 2024. On completion of Tranche Two, by Ten Eleven Ventures, Tern will hold 25.3% of Device Authority’s equity (before any dilution on exercise of share options), which would be valued at approximately US$5.4 million (approximately £4.2 million) at the valuation implied by the Device Authority Fundraising Issue Price.

Unless otherwise stated, defined terms should be given the meaning given to them in the Company’s announcement made on 27 December 2023.

Commenting Ian Ritchie, Chairman of Tern, said“Following the failure to pass the resolution required to issue new ordinary shares disapplying statutory pre-emption rights at the recent Annual General Meeting, the Tern board has been investigating ways to appropriately raise funds to protect Tern’s position in, and progress, Tern’s portfolio companies, whilst also providing Tern with funding as an AIM company. The sale of a modest proportion of our holding in Device Authority, at no discount to the value that Device Authority raised funds in December 2023, is, I believe, appropriate to meet the Company’s immediate requirements. We will continue to explore the best way to maximise shareholder value and I look forward to providing updates on our portfolio companies in due course.”

Further information on Device Authority

Device Authority is a global leader in Identity and Access Management (“IAM”) for the IoT; focused on the automotive, medical device (“IoMT”) and industrial (“IIoT”) sectors. Device Authority’s KeyScaler™ platform provides zero touch provisioning and complete automated lifecycle management for securing IoT devices and data at scale, with frictionless deployment across device provisioning, authentication, credential management, policy based end-to-end data security/encryption and secure OTA (over the air) and HSM (hardware security module) updates.

Based on Device Authority’s latest statutory accounts for the year ended 31 December 2023, as at that date it had net assets of £11,024,568 and incurred a profit for the year of £4,303,751. Given the statutory nature of these figures Tern does not consider this profit to be representative of the current business and trading performance of Device Authority.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern increases convertible loan note investment in Talking Medicines

Tern has received £270,000 of new unsecured convertible loan notes from Talking Medicines, increasing its total convertible loan note holding to approximately £0.79 million while retaining a 23.8% equity stake.

Tern Plc invests $280,000 in Device Authority convertible loan notes

Tern has invested $280,000 in new unsecured convertible loan notes issued by Device Authority, forming part of a wider funding round of up to $1.6 million from existing investors.

Surgical training technology moves closer to the centre of precision medicine

Fundamental XR is targeting a critical adoption gap in advanced healthcare by using immersive simulation to help surgical teams prepare for complex procedures with greater consistency and scale.

GLP-1 therapies move into a wider investor debate

GLP-1 therapies are moving beyond weight loss and diabetes, creating a wider investor discussion around behaviour, risk and market positioning.

Tern raises £222,000 through share placing

Tern has raised £222,000 before expenses through a placing of 37 million new ordinary shares at 0.60 pence per share, with admission to AIM expected on or around 22 May 2026.

FundamentalXR targets surgical readiness for advanced eye therapies

FundamentalXR is targeting surgical readiness for advanced eye therapies with immersive simulation designed to support real-world adoption.

Search